Semi-quantitative expression of tissue inhibitor of XXXX in @entity5 .

@entity1552 @entity1476 @entity5 @entity105 @entity1141
BACKGROUND AND OBJECTIVE: Because @entity1476 ( @entity1476 ) is associated with @entity5 progression and tissue inhibitor of @entity1476 ( @entity1552 ) selectively inhibits @entity1476 , we investigate the implication of @entity1552 in @entity105 of uterine cervix. METHODS: Twenty-six cervical @entity5 tissues and their normal counterparts were collected to evaluate semi-quantitative mRNA expression of @entity1552 . Eighty-two cervical @entity5 , 26 high-grade and 26 low-grade @entity1141 , and 26 normal tissues were collected to construct tissue microarrays for immunohistochemical study. We evaluated @entity1552 immunoreactivity using H scores in cervical @entity105 . Semi-quantitative expression of @entity1476 was also detected for comparison. RESULTS: Cervical @entity5 tissues exhibited statistically lower semi-quantitative @entity1552 (P   =   0.028) or higher @entity1476 (P   =   0.036) mRNA expression than their normal counterparts. None of cervical @entity5 tissues exerted elevated @entity1552 and reduced @entity1476 mRNA expression simultaneously. @entity5 tissues have significantly lower @entity1552 or higher @entity1476 H scores than high-grade and low-grade @entity1141 or normal tissues of uterine cervix. CONCLUSIONS: Low expression of @entity1552 or high expression of @entity1476 is semi-quantitatively demonstrated in @entity5 . @entity1552 is implicated in cervical @entity105 .
